Low-Dose Rivaroxaban to Prevent Recurrences of Venous Thromboembolism in Cancer: A Real-Life Experience with a Focus on Female Patients

Background: The way in which to prevent recurrent venous thromboembolism (VTE) is an unmet clinical need in cancer patients. International guidelines only provide conditional recommendations and do not specify which anticoagulant and dose should be used. In the last 2 years, we have been using low-d...

Descripción completa

Detalles Bibliográficos
Autores principales: Santini, Paolo, Mosoni, Carolina, D’Errico, Alessandro, Porceddu, Enrica, Lupascu, Andrea, Valeriani, Emanuele, Tondi, Paolo, Pola, Roberto, Porfidia, Angelo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573527/
https://www.ncbi.nlm.nih.gov/pubmed/37835070
http://dx.doi.org/10.3390/jcm12196427

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573527/
https://www.ncbi.nlm.nih.gov/pubmed/37835070
http://dx.doi.org/10.3390/jcm12196427

Ejemplares similares